½ÃÀ庸°í¼­
»óǰÄÚµå
1611179

°æÄ«Å×ÅÍ ±â±â ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç°º°, ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)

Transcatheter Devices Market Size, Share & Trends Analysis Report By Product (Transcatheter Embolization & Occlusion Devices, Transcatheter Replacement Devices), By Application (Cardiovascular, Oncology), By Region, And Segment Forecasts, 2025 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 150 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

°æÄ«Å×ÅÍ ±â±â ½ÃÀå ¼ºÀå°ú µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, °æÄ«Å×ÅÍ ±â±â ¼¼°è ½ÃÀå ±Ô¸ð´Â 2025-2030³â µ¿¾È 10.55%ÀÇ CAGRÀ» ±â·ÏÇϸç 2030³â±îÁö 196¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÃÖ¼Òħ½ÀÀû ½Ã¼úÀÇ Ã¤Åà Áõ°¡, ¸¸¼ºÁúȯÀÇ ³ôÀº À¯º´·ü, °³½É¼úº¸´Ù °æÄ«Å×ÅÍ Ä¡È¯¼ú ¶Ç´Â ¼öº¹¼ú¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡°¡ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. °æÄ«Å×ÅÍ ±â±âÀÇ ¼ö¿ä Áõ°¡´Â ÃÖ¼Òħ½ÀÀûÀ̰í ÀÔ¿ø ±â°£ÀÌ Âª°í ȯÀÚÀÇ È¸º¹ÀÌ ºü¸£´Ù´Â ÀåÁ¡À¸·Î ÀÎÇØ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, Abbott´Â 2019³â 4¼¼´ë MitraClip ÀåÄ¡ÀÎ MitraClip G4ÀÇ FDA ½ÂÀÎÀ» ¹Þ¾Æ ¹Ì±¹ ÀÇ»çµé¿¡°Ô ´Ù¾çÇÑ Å¬¸³ Å©±â¸¦ Á¦°øÇϰí, ½Ã¼úÀÇ ½Ç½Ã°£ Æò°¡¸¦ ¿ëÀÌÇÏ°Ô ÇÏ´Â µî ÷´Ü ½ÉÀåÆÇ¸· ±³Ã¼/º¹¿ø Ä¡·á¹ý °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. Àǻ簡 ½Â¸ðÆÇ¸· ÁúȯÀ» È¿À²ÀûÀ¸·Î Ä¡·áÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù.

´ëµ¿¸Æ ÆÇ¸· ġȯ¼ú, »ï÷ÆÇ¸· º¹¿ø¼ú, ½Â¸ðÆÇ¸· ġȯ¼ú, ½Â¸ðÆÇ¸· ġȯ¼ú ¹× º¹¿ø¼ú¿¡ »ç¿ëµÇ´Â °æÄ«Å×ÅÍ ±â±âÀÇ ±â¼ú ¹ßÀü°ú Áö¼ÓÀûÀÎ ÆÄÀÌÇÁ¶óÀÎÀÇ Áõ°¡, °³º¹ ¼ö¼úÀÇ À§ÇèÀÌ ³ôÀº ³ëÀÎÀÇ Áõ°¡°¡ ¼ö¿ä¸¦ Áõ°¡½ÃŰ´Â ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀº ÁÖ·Î ·ù¸¶Æ¼½º¼º ½ÉÀå Áúȯ, ³úÇ÷°ü Áúȯ, °íÇ÷¾Ð¼º ½ÉÀå Áúȯ, ¿°Áõ¼º ½ÉÀå Áúȯ µî ¿©·¯ ½ÉÇ÷°ü°è ÁúȯÀÇ À¯º´·ü Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù.

¹Ì±¹½ÉÀåÇùȸÀÇ 2016³â ÃßÁ¤¿¡ µû¸£¸é, ¹Ì±¹¿¡¼­´Â ´Ù¾çÇÑ ½ÉÇ÷°üÁúȯÀ¸·Î ÀÎÇØ ¾à 840,768¸íÀÌ »ç¸ÁÇÑ °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ½ÉÀåÆÇ¸· Áúȯ ȯÀÚ ¼öÀÇ Áõ°¡¿Í ½ÉÀåÆÇ¸· ±³Ã¼¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ¿¹Ãø ±â°£ µ¿¾È °æÄ«Å×ÅÍ ÆÇ¸·ÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ´Ù¸¥ ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ±×·¯³ª °æÄ«Å×ÅÍ ½ÉÀåÆÇ¸· ¼ö¸®/±³Ã¼ ÀåÄ¡ÀÇ ³ôÀº ºñ¿ë, ½ÂÀο¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©, ÀÌ·¯ÇÑ Àΰø ÆÇ¸·ÀÇ Æò»ý ¸ð´ÏÅ͸µÀÇ Çʿ伺Àº ½ÃÀå ¼ºÀåÀ» Á¦ÇÑÇÏ´Â Àå¾Ö¹° Áß ÀϺÎÀÔ´Ï´Ù.

°æÄ«Å×ÅÍ ±â±â ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • 2024³â °æÄ«Å×ÅÍ Ä¡È¯ ÀåÄ¡ ºÎ¹®ÀÌ ½ÃÀåÀ» ÁÖµµÇß½À´Ï´Ù. °æÄ«Å×ÅÍ Ä¡È¯ ÀåÄ¡´Â ±âÁ¸ÀÇ ¿Ü°úÀû ÆÇ¸· ġȯ¼ú¿¡ ´ëÇÑ ´ú ħ½ÀÀûÀÎ ´ë¾ÈÀ» ¼³¸íÇÕ´Ï´Ù.
  • 2024³â ½ÉÇ÷°ü ºÎ¹®ÀÌ ½ÃÀåÀ» ÁÖµµÇß½À´Ï´Ù. ½ÉÇ÷°üÁúȯ(CVD)ÀÇ À¯º´·ü Áõ°¡´Â ¿©ÀüÈ÷ Àü ¼¼°è ÀÌȯÀ²°ú »ç¸Á·üÀÇ ÁÖ¿ä ¿øÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù.
  • ºÏ¹Ì °æÄ«Å×ÅÍ ÀÇ·á±â±â ½ÃÀåÀº »ýȰ½À°ü º¯È­·Î ÀÎÇÑ ¸¸¼ºÁúȯ Áõ°¡·Î 2024³â 30.28%ÀÇ °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °æÄ«Å×ÅÍ ÀÇ·á±â±â ½ÃÀåÀº ½ÉÇ÷°üÁúȯÀÇ À¯º´·ü Áõ°¡¿Í °í·ÉÈ­ Àα¸ Áõ°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È Å« ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå °æÄ«Å×ÅÍ ±â±â ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • º¸Á¶ ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
    • ½ÃÀå ±âȸ ºÐ¼®
    • ½ÃÀå ±âȸ ºÐ¼®
  • °æÄ«Å×ÅÍ ±â±â ½ÃÀå ºÐ¼® Åø
    • »ê¾÷ ºÐ¼® - Porter's Five Forces ºÐ¼®
    • PESTEL ºÐ¼®

Á¦4Àå °æÄ«Å×ÅÍ ±â±â ½ÃÀå : Á¦Ç°º°, ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ °æÄ«Å×ÅÍ ±â±â ½ÃÀå º¯µ¿ ºÐ¼®
  • ¼¼°èÀÇ °æÄ«Å×ÅÍ ±â±â ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, Á¦Ç°º°, 2018-2030³â
  • °æÄ«Å×ÅÍ »öÀü¼ú°ú Æó»ö ±â±¸
    • ÄÚÀÏ
    • ÄÚÀÏ ¾øÀ½
  • °æÄ«Å×ÅÍ Ä¡È¯ µð¹ÙÀ̽º
    • °æÄ«Å×ÅÍ ´ëµ¿¸ÆÆÇ ġȯ¼ú
    • °æÄ«Å×ÅÍ Æóµ¿¸ÆÆÇ ġȯ¼ú
    • °æÄ«Å×ÅÍ ½Â¸ðÆÇ ġȯ¼ú
  • °æÄ«Å×ÅÍ ¼öº¹ Àåºñ
    • °æÄ«Å×ÅÍ ½Â¸ðÆÇ ¼öº¹¼ú
    • °æÄ«Å×ÅÍ »ï÷ÆÇ ¼öº¹¼ú

Á¦5Àå °æÄ«Å×ÅÍ ±â±â ½ÃÀå : ¿ëµµº°, ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ °æÄ«Å×ÅÍ ±â±â ½ÃÀå º¯µ¿ ºÐ¼®
  • ¼¼°èÀÇ °æÄ«Å×ÅÍ ±â±â ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, ¿ëµµº°, 2018-2030³â
  • Á¾¾çÇÐ
  • ½Å°æÇÐ
  • ºñ´¢±â°ú
  • ±âŸ

Á¦6Àå °æÄ«Å×ÅÍ ±â±â ½ÃÀå : Á¦Ç°°ú ¿ëµµ¿¡ ÀÇÇÑ Áö¿ªº°, ÃßÁ¤¡¤µ¿Ç⠺м®

  • Áö¿ª ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, 2018-2030³â
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • µ§¸¶Å©
    • ½º¿þµ§
    • ³ë¸£¿þÀÌ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • Äí¿þÀÌÆ®

Á¦7Àå °æÀï ±¸µµ

  • ½ÃÀå ÁøÃâ ±â¾÷ ºÐ·ù
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • Edwards Lifesciences Corporation
    • Abbott
    • Boston Scientific Corporation
    • Medtronic
    • Meril Lifesciences Pvt. Ltd.
    • BioVentrix, Inc.
    • Relisys Medical Devices Limited.
    • B. Braun Interventional Systems Inc.
    • Terumo Corporation
    • Stryker
  • È÷Æ®¸Ê ºÐ¼®/±â¾÷ ½ÃÀå »óȲ ºÐ¼®
  • 2024³â ±â¾÷ ½ÃÀå Á¡À¯À² ÃßÁ¤ ºÐ¼®
  • ±âŸ ÁÖ¿ä ½ÃÀå ÁøÃâ ±â¾÷ ¸®½ºÆ®
ksm 25.01.03

Transcatheter Devices Market Growth & Trends:

The global transcatheter devices market size is expected to reach USD 19.62 billion by 2030, registering a CAGR of 10.55% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increase in adoption of minimal invasive procedures, high prevalence of chronic diseases, and growing preference for transcatheter replacement or repair procedures over open heart surgery are the key factors contributing to the market growth. The demand for transcatheter devices is growing owing to the fact that they are minimally invasive in nature and offer shorter hospital stays and fast recovery to patients. This is another major factor positively impacting the market growth. Also, key players are focusing on developing advanced heart valve replacement/ repair therapies, for instance, Abbott in 2019 received a FDA approval for its fourth-generation MitraClip device - MitraClip G4 that offers physicians in the U.S. with an extensive range of clip sizes, and facilitates real time assessment of procedure, thereby enabling doctors to efficiently treat mitral valve disease.

The growing technological advancement and constantly increasing volume of transcatheter devices in the pipeline for aortic valve replacement and repair, tricuspid valve repair, mitral valve replacement and repair, coupled with a growing geriatric population at high risk for open surgery are some of the factors boosting their demand. The growth is mainly driven by increasing prevalence of several cardiovascular disorders such as rheumatic heart disorders, cerebrovascular diseases, hypertensive heart diseases, and inflammatory heart diseases.

According to American Heart Association estimates in 2016, nearly 840,768 deaths were registered in the U.S. due to various cardiovascular diseases. The increasing patient pool for heart valve disorders and growing demand for heart valve replacement are other key factors expected to drive growth of transcatheter valves during the forecast period. However, high costs of transcatheter heart valve repair/replacement devices, a stringent regulatory framework for their approval, and the need for lifelong surveillance of these artificial valves are some of the barriers limiting market growth.

Transcatheter Devices Market Report Highlights:

  • The transcatheter replacement devices segment dominated the market in 2024. Transcatheter replacement devices offer a less invasive alternative to traditional surgical valve replacements.
  • The cardiovascular segment dominated the market in 2024. The increasing prevalence of cardiovascular diseases (CVDs) remains the leading cause of morbidity and mortality worldwide.
  • The North America transcatheter devices market held the largest revenue share of 30.28% in 2024 due to increasing cases of chronic diseases due to lifestyle changes.
  • The Asia Pacific transcatheter medical devices market is projected to witness significant growth over the forecast period owing to increasing prevalence of cardiovascular diseases and a rising aging population.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Transcatheter Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising cardiovascular disease prevalence
      • 3.2.1.2. Advancements in minimally invasive technologies
      • 3.2.1.3. Growing geriatric population
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of devices and procedures
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Expansion into emerging economies
    • 3.2.4. Market Opportunities Analysis
      • 3.2.4.1. Clinical risks and complications
  • 3.3. Transcatheter Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Transcatheter Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Transcatheter Devices Market Movement Analysis
  • 4.3. Global Transcatheter Devices Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Transcatheter Embolization and Occlusion Devices
    • 4.4.1. Transcatheter Embolization and Occlusion Devices Transcatheter Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Coils
      • 4.4.2.1. Coils Transcatheter Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.2. Pushable Coils
        • 4.4.2.2.1. Pushable coils Transcatheter Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.3. Detachable Coils
        • 4.4.2.3.1. Detachable Coils Transcatheter Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Non Coils
      • 4.4.3.1. Non Coils Transcatheter Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.3.2. Flow Diverting Devices
        • 4.4.3.2.1. Detachable Coils Transcatheter Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.3.3. Embolization Particles
        • 4.4.3.3.1. Detachable Coils Transcatheter Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.3.4. Liquid Embolics
        • 4.4.3.4.1. Detachable Coils Transcatheter Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.3.5. Other Embolization and Occlusion Devices
        • 4.4.3.5.1. Other Embolization and Occlusion Devices Transcatheter Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.3.6. Accessories
        • 4.4.3.6.1. Accessories Transcatheter Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Transcatheter Replacement Devices
    • 4.5.1. Transcatheter Replacement Devices Transcatheter Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Transcatheter Aortic Valve Replacement
      • 4.5.2.1. Transcatheter Aortic Valve Replacement Transcatheter Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Transcatheter Pulmonary Valve Replacement
      • 4.5.3.1. Transcatheter Pulmonary Valve Replacement Transcatheter Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Transcatheter Mitral Valve Replacement
      • 4.5.4.1. Transcatheter Mitral Valve Replacement Transcatheter Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Transcatheter Repair Devices
    • 4.6.1. Transcatheter Repair Devices Transcatheter Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.2. Transcatheter Mitral Valve Repair
      • 4.6.2.1. Transcatheter Repair Devices Transcatheter Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.3. Transcatheter Tricuspid Valve Repair
      • 4.6.3.1. Transcatheter Repair Devices Transcatheter Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Transcatheter Devices Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Transcatheter Devices Market Movement Analysis
  • 5.3. Global Transcatheter Devices Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Oncology
    • 5.4.1. Oncology Transcatheter Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Neurology
    • 5.5.1. Neurology Transcatheter Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Urology
    • 5.6.1. Urology Transcatheter Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Transcatheter Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Transcatheter Devices Market: Regional Estimates & Trend Analysis By Product and Application

  • 6.1. Regional Dashboard
  • 6.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 6.3. North America
    • 6.3.1. North America Transcatheter Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Scenario
      • 6.3.2.4. Reimbursement Scenario
      • 6.3.2.5. U.S. Transcatheter Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Scenario
      • 6.3.3.4. Reimbursement Scenario
      • 6.3.3.5. Canada Transcatheter Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Scenario
      • 6.3.4.4. Reimbursement Scenario
      • 6.3.4.5. Mexico Transcatheter Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Europe Transcatheter Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Scenario
      • 6.4.2.4. Reimbursement Scenario
      • 6.4.2.5. UK Transcatheter Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Scenario
      • 6.4.3.4. Reimbursement Scenario
      • 6.4.3.5. Germany Transcatheter Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Scenario
      • 6.4.4.4. Reimbursement Scenario
      • 6.4.4.5. France Transcatheter Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Scenario
      • 6.4.5.4. Reimbursement Scenario
      • 6.4.5.5. Italy Transcatheter Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Scenario
      • 6.4.6.4. Reimbursement Scenario
      • 6.4.6.5. Spain Transcatheter Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Denmark
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Scenario
      • 6.4.7.4. Reimbursement Scenario
      • 6.4.7.5. Denmark Transcatheter Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.8. Sweden
      • 6.4.8.1. Key Country Dynamics
      • 6.4.8.2. Competitive Scenario
      • 6.4.8.3. Regulatory Scenario
      • 6.4.8.4. Reimbursement Scenario
      • 6.4.8.5. Sweden Transcatheter Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.9. Norway
      • 6.4.9.1. Key Country Dynamics
      • 6.4.9.2. Competitive Scenario
      • 6.4.9.3. Regulatory Scenario
      • 6.4.9.4. Reimbursement Scenario
      • 6.4.9.5. Norway Transcatheter Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific Transcatheter Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Scenario
      • 6.5.2.4. Reimbursement Scenario
      • 6.5.2.5. Japan Transcatheter Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. China
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Scenario
      • 6.5.3.4. Reimbursement Scenario
      • 6.5.3.5. China Transcatheter Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Scenario
      • 6.5.4.4. Reimbursement Scenario
      • 6.5.4.5. India Transcatheter Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Scenario
      • 6.5.5.4. Reimbursement Scenario
      • 6.5.5.5. South Korea Transcatheter Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Australia
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Scenario
      • 6.5.6.4. Reimbursement Scenario
      • 6.5.6.5. Australia Transcatheter Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Thailand
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Scenario
      • 6.5.7.4. Reimbursement Scenario
      • 6.5.7.5. Thailand Transcatheter Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America Transcatheter Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Scenario
      • 6.6.2.4. Reimbursement Scenario
      • 6.6.2.5. Brazil Transcatheter Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Scenario
      • 6.6.3.4. Reimbursement Scenario
      • 6.6.3.5. Argentina Transcatheter Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Middle East & Africa
    • 6.7.1. Middle East & Africa Transcatheter Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Scenario
      • 6.7.2.4. Reimbursement Scenario
      • 6.7.2.5. South Africa Transcatheter Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Saudi Arabia
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Scenario
      • 6.7.3.4. Reimbursement Scenario
      • 6.7.3.5. Saudi Arabia Transcatheter Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Scenario
      • 6.7.4.4. Reimbursement Scenario
      • 6.7.4.5. UAE Transcatheter Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory Scenario
      • 6.7.5.4. Reimbursement Scenario
      • 6.7.5.5. Kuwait Transcatheter Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Key Company Profiles
    • 7.2.1. Edwards Lifesciences Corporation
      • 7.2.1.1. Company Overview
      • 7.2.1.2. Financial Performance
      • 7.2.1.3. Service Benchmarking
      • 7.2.1.4. Strategic Initiatives
    • 7.2.2. Abbott
      • 7.2.2.1. Company Overview
      • 7.2.2.2. Financial Performance
      • 7.2.2.3. Service Benchmarking
      • 7.2.2.4. Strategic Initiatives
    • 7.2.3. Boston Scientific Corporation
      • 7.2.3.1. Company Overview
      • 7.2.3.2. Financial Performance
      • 7.2.3.3. Product Benchmarking
      • 7.2.3.4. Strategic Initiatives
    • 7.2.4. Medtronic
      • 7.2.4.1. Company Overview
      • 7.2.4.2. Financial Performance
      • 7.2.4.3. Product Benchmarking
      • 7.2.4.4. Strategic Initiatives
    • 7.2.5. Meril Lifesciences Pvt. Ltd.
      • 7.2.5.1. Company Overview
      • 7.2.5.2. Financial Performance
      • 7.2.5.3. Product Benchmarking
      • 7.2.5.4. Strategic Initiatives
    • 7.2.6. BioVentrix, Inc.
      • 7.2.6.1. Company Overview
      • 7.2.6.2. Financial Performance
      • 7.2.6.3. Product Benchmarking
      • 7.2.6.4. Strategic Initiatives
    • 7.2.7. Relisys Medical Devices Limited.
      • 7.2.7.1. Company Overview
      • 7.2.7.2. Financial Performance
      • 7.2.7.3. Product Benchmarking
      • 7.2.7.4. Strategic Initiatives
    • 7.2.8. B. Braun Interventional Systems Inc.
      • 7.2.8.1. Company Overview
      • 7.2.8.2. Financial Performance
      • 7.2.8.3. Product Benchmarking
      • 7.2.8.4. Strategic Initiatives
    • 7.2.9. Terumo Corporation
      • 7.2.9.1. Company Overview
      • 7.2.9.2. Financial Performance
      • 7.2.9.3. Product Benchmarking
      • 7.2.9.4. Strategic Initiatives
    • 7.2.10. Stryker
      • 7.2.10.1. Company Overview
      • 7.2.10.2. Financial Performance
      • 7.2.10.3. Product Benchmarking
      • 7.2.10.4. Strategic Initiatives
  • 7.3. Heat Map Analysis/ Company Market Position Analysis
  • 7.4. Estimated Company Market Share Analysis, 2024
  • 7.5. List of Other Key Market Players
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦